ºÚÁϳԹÏÍø

CLEVELAND - A new sporadic prion protein disease has been discovered. Variably protease-sensitive prionopathy (VPSPr), as it has been named, is the second type of complete sporadic disease to be identified since Creutzfeldt-Jakob disease (CJD) was reported in the 1920s. The landmark finding from the...

CLEVELAND - Researchers at ºÚÁϳԹÏÍø developed techniques to quickly identify evolution of drug resistance in strains of malaria. Their goal is to enable the medical community to react quickly to inevitable resistance and thereby save lives while increasing the lifespan of drug...

CLEVELAND - Jonathan Stamler, MD, Director of the Institute for Transformative Molecular Medicine and the Robert S. and Sylvia K. Reitman Family Foundation Distinguished Chair in Cardiovascular Innovation at the ºÚÁϳԹÏÍø and University Hospitals Harrington-McLaughlin Heart & V...

CLEVELAND - The ºÚÁϳԹÏÍø/University Hospitals Case Medical Center Center for AIDS Research (CFAR) announced today it has received a five-year renewal grant from the National Institutes of Health (NIH) for $9 million. The CFAR provides clinical and technological support to rese...

CLEVELAND - Cynthia Owusu, MD, associate professor at ºÚÁϳԹÏÍø and geriatric-oncologist at University Hospitals Case Medical Center, the School’s primary affiliate, has received nearly $500,000 from Susan G. Komen For the Cure to fund a novel three-year study aimed at improvin...

CLEVELAND - Prostate cancer is the second leading cause of cancer-related deaths in men with an estimated 192,280 new cases diagnosed in the US in 2009 (Jemal 2009). Diet is considered one of the most important controllable risk factors for inflammation and prostate diseases including benign prostat...

CLEVELAND - Using chemical labeling and mass spectrometry-based techniques, Mark Chance, PhD, director of the ºÚÁϳԹÏÍø School of Medicine Center for Proteomics and Bioinformatics and professor of physiology and biophysics; Sayan Gupta, PhD, instructor at the Case Center for Pr...

CLEVELAND - The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) has named ºÚÁϳԹÏÍø School of Medicine as the lead institution of an International Center of Excellence for Malaria Research (ICEMR). The $7.9M seven-...

CLEVELAND - Athersys, Inc. (NASDAQ: ATHX) and its collaborators, including the Center for Stem Cell and Regenerative Medicine (CSCRM) and ºÚÁϳԹÏÍø (ºÚÁϳԹÏÍø), announced today that they have been awarded $1 million through the Ohio Third Frontier Biomedical Program to support resea...

CLEVELAND - ºÚÁϳԹÏÍø's School of Medicine and Frances Payne Bolton School of Nursing have received a $640,000 grant from the Josiah Macy, Jr. Foundation to fund the new Interprofessional Learning Exchange and Development (I-LEAD) Program. The project will involve several exper...